FDA 510(k) clearance

what OEM buyers need to understand before sourcing

A supplier saying "we have FDA 510(k)" is not the end of diligence. It is the start of document matching.

What does FDA 510(k) clearance actually tell an OEM buyer?

510(k) clearance is a signal that a device submission was cleared by FDA's Center for Devices and Radiological Health, or CDRH, for marketing under a specific device description and intended use. That is the useful part. The dangerous mistake is stretching that signal too far.

A 510(k) can support a sourcing conversation. It does not prove all of the following at once:

  • that the factory you are speaking to is the legal submitter
  • that your exact SKU is covered
  • that a relabeled or modified OEM version fits the same cleared configuration
  • that the current production line is the one tied to the cleared device
  • that every accessory, material, or software revision sits inside the same scope as reflected in the public record

The clean distinction is this: a 510(k) is evidence about a cleared device record. It is not a shortcut around supplier verification. ([Agence Octo methodology])

How should buyers use the Agence Octo 510(k) Match Stack?

The Agence Octo 510(k) Match Stack is a five-point screen for OEM buyers reviewing medical-device supplier claims.

Stack layer What to check Why it matters
1. K-number Ask for the exact K-number, not a screenshot or badge Real checks start with an identifiable record
2. Submitter match Compare the listed submitter to the company selling to you A mismatch does not prove a problem. It sets the burden of proof.
3. Device description match Compare cleared device name, specs, and product code to the offered item Small naming overlap can hide a different device scope
4. Indications-for-use match Read the intended-use language in the summary Different use claims can break the commercial fit
5. Relationship proof Ask how the seller is connected to the clearance holder OEM, contract manufacturer, distributor, and trading company are not the same role

Watch the stack, not any single signal.

A supplier can show a real K-number and still be the wrong commercial counterparty for your deal. A submitter mismatch on its own is not proof of fraud; legitimate licensing, contract manufacturing, or distribution structures exist. But a submitter mismatch stacked with vague product specs, no written authorization, and evasive answers about the legal manufacturer is the canonical coverage-gap pattern. A concise example: the FDA record lists Company A as submitter for a patient monitor, while Company B offers you a private-label version with different model numbers and no authorization letter. ([Agence Octo methodology])

What should you ask for before treating a 510(k) claim as usable?

Ask for documents that connect the public record to the product in front of you.

A practical evidence path is simple: pull the K-number from FDA's public 510(k) database, open the summary PDF, confirm the submitter name, device name, product code, and indications-for-use language, then compare those fields to the quote, spec sheet, labeling, and seller identity in your deal file. ([Official sources], [Agence Octo methodology])

Practical checklist

  1. Exact 510(k) number
  2. FDA database link or 510(k) summary PDF
  3. Full legal name of the clearance holder
  4. Product code and device name used in the clearance
  5. Indications-for-use statement
  6. Written explanation of the supplier's role: clearance holder, OEM manufacturer, contract manufacturer, distributor, or trader
  7. Authorization letter or commercial agreement if the seller is not the listed submitter
  8. Current product spec sheet with model numbers and revision history
  9. Labeling samples showing brand, manufacturer, and device identifiers
  10. Factory name and address for the actual production site

If the supplier cannot assemble that packet, you do not have a verified 510(k) sourcing claim. You have a sales claim.

What are the most common 510(k) sourcing mistakes buyers make?

The first mistake is confusing product clearance with factory credibility.

The second is assuming a private-label version inherits the same status without checking whether the marketed configuration appears to have changed in ways that may fall outside the public record you reviewed. A new enclosure, software change, accessory bundle, labeling shift, or intended-use tweak can matter to the sourcing analysis. This is a sourcing signal, not regulatory confirmation. ([Agence Octo methodology])

The third is accepting screenshots instead of record-level evidence. A screenshot is marketing. A K-number is traceable.

The fourth is treating "FDA registered" and "510(k) cleared" as interchangeable. They are different signals. Buyers who collapse them usually stop diligence too early. ([Agence Octo methodology])

When should an OEM buyer slow down or walk away?

Walk away if the supplier will not provide the K-number.

Walk away if the company name on the clearance has no documented relationship to the seller.

Walk away if the offered product description drifts from the cleared device and the supplier answers with generalities.

Walk away if the supplier uses the phrase "same as FDA approved" but cannot point to the actual CDRH record. That wording does not prove deception on its own. It does show the seller is speaking in marketing shorthand where buyers need precision. ([Agence Octo methodology])

Walk away if the factory, trading company, and brand owner each give a different story about who holds the clearance.

Weak device sellers rarely fail because one file is missing. They fail because the files do not agree with each other.

How can Periscope help before you commit to a supplier?

Periscope helps buyers pressure-test product claims before they become expensive sourcing mistakes.

If a supplier's FDA story is doing too much work in the sale, slow the process down and verify the match between the public clearance record and the commercial entity offering the product.

Use Periscope to surface entity, product, and record mismatches before you commit to tooling, inventory, or launch timing.

Sources

Official sources

  • U.S. Food and Drug Administration (FDA) — CDRH 510(k) overview and public 510(k) database/search resources
  • FDA — 510(k) Premarket Notification program pages
  • FDA — Device classification and product code database resources

Named third-party sources

  • No named third-party sources used in this iteration

Seller-reported sources

  • Synthetic article for taxonomy coverage; no seller-reported posts cited in this iteration

Agence Octo methodology

  • Agence Octo 510(k) Match Stack — internal sourcing framework for checking whether a public clearance record aligns with the commercial seller, product description, and OEM relationship
  • Observational rule used in this article: public clearance records are sourcing signals that require entity, product, and relationship matching before buyers rely on them commercially

This article is sourcing intelligence, not legal, customs, or regulatory advice. For compliance decisions, consult qualified regulatory, legal, or customs professionals.